DADTF yields 100000.00% · PFE yields 6.20%● Live data
📍 DADTF pulled ahead of the other in Year 1
Combined, DADTF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DADTF + PFE for your $10,000?
DataDot Technology Limited, together with its subsidiaries, manufactures and distributes asset identification, management, protection, and authentication solutions in Asia, the Americas, Africa, Australia, and Europe. The company operates through three segments: DataDotDNA, DataTraceID, and DataDot-Vault. It offers DataDotDNA polymer and metallic microdots; asset registers, which are databases that record asset identification data and are accessible by law enforcement agencies and insurance investigators; security DataTraceID authentication solutions; and DataDot-VAULT asset protection products and services. The company also provides theft deterrence solutions, such as ToolMate that protects tools, as well as deters thieves using the microdot identification technology; and PartMate, which combines microdots with encoded serial numbers and a hidden tracer that can be viewed with a black-light. In addition, it offers authentication solutions for liability reduction, warranty claims, counterfeit detection, track and trace, grey market/diversion, supply chain management, enhanced packaging, retail loss prevention, credentials/ID cards, and document security. Further, the company offers DataDotDNA National Register, a law enforcement resource center that allows customers to verify the original owner of assets protected by DataDotDNA. Additionally, it operates as a re-seller of PadJack's range of network security products. The company sells its products to governments, police, insurance, and other companies within the automotive industry through a network of distributors. DataDot Technology Limited incorporated in 2000 and is based in Brookvale, Australia.
Full DADTF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.